Beauty Health terminates CRO Daniel Watson without cause, effective Oct 14

SkinHealth Systems Inc.

Daniel Watson terminated as Chief Revenue Officer without cause, effective October 14, 2024.
Watson will remain as advisor until no later than December 31, 2024.
Separation agreement pending; amendment to 8-K to be filed within four business days of agreement.
Termination not related to any disagreement on financial reporting, operations, or policies.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Daniel Watson

Chief Revenue Officer

SKIN · SkinHealth Systems Inc.

Effective: 2024-10-14
Filed: October 15, 2024, 7:59 PM ET

On October 8, 2024, the Board of Directors (the "Board") of The Beauty Health Company (the "Company") terminated Daniel Watson's employment as Chief Revenue Officer of the Company without cause, effective as of October 14, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel Watson was terminated as Chief Revenue Officer at SkinHealth Systems Inc..

Action: terminated
Role: Chief Revenue Officer

Exact text from the filing

On October 8, 2024, the Board of Directors (the "Board") of The Beauty Health Company (the "Company") terminated Daniel Watson's employment as Chief Revenue Officer of the Company without cause, effective as of October 14, 2024.

View on SEC.gov

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-042835

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.